SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 39.79 |
| Enterprise Value ($M) | 34.98 |
| Book Value ($M) | 2.73 |
| Book Value / Share | 0.07 |
| Price / Book | 14.55 |
| NCAV ($M) | 0.52 |
| NCAV / Share | 0.01 |
| Price / NCAV | 76.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.84 |
| Return on Assets (ROA) | -0.98 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.12 |
| Current Ratio | 1.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.23 |
| Assets | 16.45 |
| Liabilities | 13.71 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -13.74 |
| Net Income | -11.16 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -11.90 |
| Cash from Investing | -0.18 |
| Cash from Financing | 16.91 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | O'heeron Pete | 18.20 | ||
| 13G/A | BlackRock, Inc. | 5.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 62,818 | 201,285 | 31.21 | |
| 68,092 | 233,415 | 29.17 | |
| 50,345 | 157,656 | 31.93 | |
| 77,350 | 168,987 | 45.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EVOK – Evoke Pharma, Inc. | EYEN – Eyenovia, Inc. |
| FBIO – Fortress Biotech, Inc. | FBRX – Forte Biosciences, Inc. |
| FENC – Fennec Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io